German China India

USA: Pharma Appointment

Aqeel Fatmi to Join Elite Pharmaceuticals’ Board of Directors

| Editor: Ahlam Rais

Elite Pharmaceuticals has recently announced the appointment of Aqeel A. Fatmi, Ph.D. to its Board of Directors.
Gallery: 1 image
Elite Pharmaceuticals has recently announced the appointment of Aqeel A. Fatmi, Ph.D. to its Board of Directors. (Source: Deposit Photos)

Dr. Fatmi has a rich experience of serving the pharmaceutical industry for more than 35 years. He has also played an eminent role in advisory boards across various prominent companies across the globe.

New Jersey/USA – Elite Pharmaceuticals, the specialty pharmaceutical company has recently announced the appointment of Aqeel A. Fatmi, Ph.D. to its Board of Directors. Dr. Fatmi qualifies as an independent director under the Nasdaq Rules. He has acquired more than 35 years of experience in the pharmaceutical industry while serving in leadership positions and advisory boards for multiple global companies. Dr. Fatmi has expertise and experience in strategic development, mergers and acquisitions, research and development, supply chain management, operations excellence and business development.

He currently heads his own consulting firm that advises in all areas of pharmaceutical development and manufacturing. Prior to consulting, Dr. Fatmi was employed by Humanwell Healthcare Group and assisted with the integration of Epic Pharma after the acquisition by Humanwell. He was Executive Vice President of Global Research and Development and Operations and served on the Global Leadership Team for Banner Pharmacaps. Dr. Fatmi was also Chief Scientific Officer for Patheon Pharmaceuticals and Banner Life Sciences after its acquisition of Banner.

Comments are being loaded ....

Leave a comment

The comment is checked by an editor and will be released soon.

  1. Avatar
    Avatar
    Edited by at
    Edited by at
    1. Avatar
      Avatar
      Edited by at
      Edited by at

Comments are being loaded ....

Report comment

Kommentar Freigeben

Der untenstehende Text wird an den Kommentator gesendet, falls dieser eine Email-hinterlegt hat.

Freigabe entfernen

Der untenstehende Text wird an den Kommentator gesendet, falls dieser eine Email-hinterlegt hat.

copyright

This article is protected by copyright. You want to use it for your own purpose? Infos can be found under www.mycontentfactory.de (ID: 45439714 / Pharma & Food)